US82489T1043 - Common Stock - After market: 187.83 0 (0%)
Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road.
These stocks are all down by at least 42% from their all-time highs despite impressive performances from their underlying businesses.
Bank of America reaffirmed its Buy rating on ShockWave Medical (SWAV) after its shares witnessed a sharp in reaction to a deal to acquire Neovasc (NVCN). Read the full story here.
Shockwave Medical (SWAV) is acquiring Neovasc (NVCN) for an enterprise value of ~$100M.Canada-based medical device maker Neovasc is developing a minimally invasive treatment for...
Neovasc’s Innovative Reducer System Will Target the Estimated $5 Billion Refractory Angina Market Shockwave Medical Announces Preliminary Fourth Quarter...
ShockWave Medical CEO Doug Godshall says successful companies don't follow a formula.
SANTA CLARA, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of...
It's going to take more than a recession to stop these two from delivering outsized gains to patient investors.
The road ahead of these businesses is a lot smoother than you'd think by looking at their stock prices.
Although the market shows signs of improvement, the waters are still choppy enough for investors to focus on index funds to buy.
Some of the world's most successful investors can't get enough of The Trade Desk, Shockwave Medical, and SoFi Technologies.
SANTA CLARA, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy...
Long-term investors should consider the high upside of these growth stocks.
The Relative Strength (RS) Rating for InMode stock moved up into a higher percentile Wednesday, as it got a lift from 64 to 78.
SANTA CLARA, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy...
One's a growth stock and the other pays a dividend but both of these healthcare businesses have what it takes to reliably outperform.
Bitcoin hit a two-year low while Meta and Tesla were in focus.
Macroeconomic pressures aren't much of an issue when all your customers are cardiovascular surgeons.
SWAV earnings call for the period ending September 30, 2022.
SANTA CLARA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of...